|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/50 | |
| C07K 14/195 | |||
| C12N 9/10 | |||
| C12N 1/21 | |||
| C12P 19/28 |
| (11) | Number of the document | 3177325 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15766054.9 |
| Date of filing the European patent application | 2015-08-06 | |
| (97) | Date of publication of the European application | 2017-06-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-04-01 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2015/068203 |
| Date | 2015-08-06 |
| (87) | Number | WO 2016/020499 |
| Date | 2016-02-11 |
| (30) | Number | Date | Country code |
| 201462035360 P | 2014-08-08 | US |
| (72) |
FARIDMOAYER, Amirreza, CH
|
| (73) |
GlaxoSmithKline Biologicals S.A.,
Rue de l`Institut, 89, 1330 Rixensart,
BE
|
| (54) | MODIFIED HOST CELLS AND HYBRID OLIGOSACCHARIDES FOR USE IN BIOCONJUGATE PRODUCTION |
| MODIFIED HOST CELLS AND HYBRID OLIGOSACCHARIDES FOR USE IN BIOCONJUGATE PRODUCTION |